CALCA and migraine disorder: In recent years, the identification of calcitonin gene-related peptide (CGRP) as a critical contributor in migraine pathophysiology [14] represented a game changer, as further revolutionary research findings led to the development of a new class of injectable migraine preventives called the anti-CGRP monoclonal antibodies (anti-CGRP MAbs) [15].